These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21765952)

  • 1. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
    Youssef HMK; Radi DA; Abd El-Azeem MA
    Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
    [No Abstract]   [Full Text] [Related]  

  • 3. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.
    Qiao WL; Shi BW; Han YD; Tang HM; Lin J; Hu HY; Lin Q
    Oncol Lett; 2018 Jun; 15(6):8796-8804. PubMed ID: 29805619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer.
    Liu F; Cao Q; Liu N; Li C; You C; Liu C; Xue L; Luo R
    Gastroenterol Res Pract; 2014; 2014():498246. PubMed ID: 24799889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
    Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 is a favorable prognostic marker for colorectal cancer.
    Lin Y; Xu J; Su H; Zhong W; Yuan Y; Yu Z; Fang Y; Zhou H; Li C; Huang K
    Clin Transl Oncol; 2015 Jan; 17(1):50-6. PubMed ID: 25015721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
    Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
    J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
    Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.
    Chen L; Jiang B; Wang Z; Liu M; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
    Clin Transl Oncol; 2014 Mar; 16(3):285-92. PubMed ID: 23860725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.